The controversy over testosterone therapy rages on, with an FDA advisory panel recommending limiting the use of the hormone – noting that there is minimal evidence that testosterone-boosting drugs are effective for treating common signs of aging in men.
The U.S. Food and Drug Administration (FDA) recently warned that olmesartan – the popular blood pressure drug branded as Benicar, Benicar HCT, Azor and Tribenzor – can cause severe intestinal problems, also known as sprue-like enteropathy.
Testosterone therapy has been widely touted as a way to help aging men boost diminished energy. FDA to Review Testosterone Therapy Safety. The appeal of the hormone indisputable – it can build muscle, increase bone density, improve libido and influence emotional and physical well being.
Risk of Liver Damage Cited
High doses of acetaminophen may lead to serious liver damage, and as a result, the FDA is recommending that health care professionals discontinue prescribing and dispensing prescription combination drug products that contain more than 325 milligrams of the popular painkiller.
When consumers take dietary supplements to burn fat or speed weight loss, they made be putting themselves at serious risk for liver damage.
In fact, dietary or health supplements – which include herbal products, vitamins, minerals, and any product that is not being marketed as a food or drug – account for nearly 20 percent of drug-related liver injuries that turn up in hospitals, up from 7 percent a decade ago, according to an analysis by a national network of liver specialists.
The U.S. Food and Drug Administration (FDA) warned that Onfi, an anti seizure medication, can trigger serious and potentially fatal skin reactions.
In a recently released public safety announcement, the FDA said Onfi (clobazam) can cause rare but devastating skin reactions possibly resulting in permanent harm and death.
Following more than 750 incidents of a rare strain of fungal meningitis and other related infections last year, the New England Compounding Center (NECC), in Framingham, Massachusetts recalled all of its products and was been stripped of its pharmacy license in late 2012.
The number of Americans taking cholesterol-lowering statin drugs could double under new guidelines released by the American College of Cardiology and the American Heart Association.
According to the new study, obesity should be treated like a disease and cholesterol-lowering statins can prevent cardiovascular disease in more Americans than previously thought.
